CORETERRA NEUROSCIENCE
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99435536
- Mark type
- Stylized text
- Filed
- 09 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neuropsychiatric conditions, namely, autism spectrum disorder and its symptoms
- Class 042 — Scientific and technological services: Pharmaceutical research in the field of treatments for neuropsychiatric conditions, namely, autism spectrum disorder and its symptoms
Owner
- Coreterra Therapeutics, Inc., Rochelle Park, NJ, US
- Coreterra Therapeutics, Inc., Rochelle Park, NJ, US
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 27 Feb 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Oct 2025 — NEW APPLICATION ENTERED